DryShips Inc. (NASDAQ: DRYS) announced that it will release its results for the fourth quarter 2015 after the market closes in New York on Tuesday, March 8, 2016.
DryShips, Inc. (NASDAQ:DRYS) belongs to Services sector. Its weekly performance is 28.57%. On last trading day company shares ended up at $0.14.
On 29 February, Intrexon Corporation (NYSE: XON) reported Q4 EPS of ($0.28), $0.10 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $41.5 million versus the consensus estimate of $41.82 million.
Intrexon Corporation (NYSE:XON) shares decreased -0.67% in last trading session and ended the day at $37.03. XON Gross Margin is 29.00% and its return on assets is -4.10%. Intrexon Corporation (NYSE:XON) quarterly performance is 6.32%.
Western Alliance Bancorporation (NYSE:WAL) announced that Chief Financial Officer Dale Gibbons will present at the 2016 RBC Capital Markets Financial Institutions Conference on Tuesday, March 8, 2016, at 1:05 p.m. ET.
On 04 March, Western Alliance Bancorporation (NYSE:WAL) shares increased 0.94% and was closed at $32.36. WAL EPS growth in last 5 year was 66.20%. Western Alliance Bancorporation (NYSE:WAL) year to date (YTD) performance is -9.76%.
On 3 March, The Colorado Bankers Association awarded Tim Laney, CEO of National Bank Holdings Corporation (NYSE:NBHC) and Community Banks of Colorado, a division of NBH Bank, the Banker of Distinction Award. The award recognized the importance of the community banking spirit, and dedication and support of activities vital to the health of local businesses and people in the community. The Colorado Bankers Association annually recognizes the contributions of bankers who have provided outstanding community leadership.
National Bank Holdings Corp. (NYSE:NBHC) ended the last trading day at $19.90. Company weekly volatility is calculated as 1.94% and price to cash ratio as 3.20. National Bank Holdings Corp. (NYSE:NBHC) showed a weekly performance of 1.58%.
On 1st March, Synthetic Biologics, Inc. (NYSE MKT: SYN), announced that the U.S. Patent and Trademark Office (USPTO) issued Notices of Allowance for three patent applications which cover composition of matter claims and methods of protecting the gut microbiome from certain beta-lactam antibiotics for the prevention of C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). These new allowances further strengthen the Company’s novel proprietary candidate, SYN-004, which is also covered by a composition of matter patent in the U.S.
Synthetic Biologics Inc. (NYSEMKT:SYN) shares increased 1.10% in last trading session and ended the day at $1.84. SYN return on assets is -180.30%. Synthetic Biologics Inc. (NYSEMKT:SYN) quarterly performance is -35.89%.